Suppr超能文献

影响细胞减灭术和腹腔内热灌注化疗后感染并发症的预后因素:来自三级转诊中心的结果

Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center.

作者信息

Cardi Maurizio, Sibio Simone, Di Marzo Francesco, Lefoche Francesco, d'Agostino Claudia, Fonsi Giovanni Battista, La Torre Giuseppe, Carbonari Ludovica, Sammartino Paolo

机构信息

Dipartimento di Chirurgia Pietro Valdoni, Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy.

Chirurgia Generale, Ospedale Versilia, Via Aurelia 335, 55041 Lido di Camaiore, Italy.

出版信息

Gastroenterol Res Pract. 2019 May 2;2019:2824073. doi: 10.1155/2019/2824073. eCollection 2019.

Abstract

BACKGROUND

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application. The aim of this study was to report postoperative infectious complications and investigate possible correlations with the preoperative nutritional status and other prognostic factors in patients with peritoneal metastases treated with CRS and HIPEC.

METHODS

For the study, we reviewed the clinical records of all patients with peritoneal metastases from different primary cancers treated with CRS and HIPEC in our Institution from November 2000 to December 2017. Patients were divided according to their nutritional status (SGA) into groups A (well-nourished) and B/C (mild or severely malnourished, respectively). Possible statistical correlations between risk factors and postoperative complication rates have been investigated by univariate and multivariate analysis.

RESULTS

Two hundred patients were selected and underwent CRS and HIPEC during the study period. Postoperative complications occurred in 44% of the patients, 35.3% in SGA-A patients, and 53% in SGA-B/C patients. Cause of complications was infective in 42, noninfective in 37, and HIPEC related in 9 patients. Infectious complications occurred more frequently in SGA-B/C patients (32.6% vs. 9.8% of SGA-A patients). The most frequent sites of infection were surgical site infections (SSI, 35.7%) and central line-associated bloodstream infections (CLABSI, 26.2%). The most frequent isolated species was Candida (22.8%). ASA score, blood loss, performance status, PCI, large bowel resection, postoperative serum albumin levels, and nutritional status correlated with higher risk for postoperative infectious complications.

CONCLUSIONS

Malnourished patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are more prone to postoperative infectious complications, and adequate perioperative nutritional support should be considered, including immune-enhancing nutrition. Sequential monitoring of common sites of infection, antifungal prevention of candidiasis, and careful patient selection should be implemented to reduce the complication rate.

摘要

背景

细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC)在部分患者中显示出了良好的效果。高发病率限制了其广泛应用。本研究的目的是报告接受CRS和HIPEC治疗的腹膜转移患者术后感染性并发症,并探讨其与术前营养状况及其他预后因素之间可能存在的相关性。

方法

本研究回顾了2000年11月至2017年12月期间在我院接受CRS和HIPEC治疗的所有不同原发癌腹膜转移患者的临床记录。根据营养状况(主观全面评定法,SGA)将患者分为A组(营养良好)和B/C组(分别为轻度或重度营养不良)。通过单因素和多因素分析研究危险因素与术后并发症发生率之间可能存在的统计学相关性。

结果

研究期间共选取200例患者接受CRS和HIPEC治疗。44%的患者发生术后并发症,SGA - A组患者为35.3%,SGA - B/C组患者为53%。并发症原因中,42例为感染性,37例为非感染性,9例与HIPEC相关。SGA - B/C组患者感染性并发症发生率更高(32.6% vs. SGA - A组患者的9.8%)。最常见的感染部位是手术部位感染(SSI,35.7%)和中心静脉导管相关血流感染(CLABSI,26.2%)。最常见的分离菌种是念珠菌(22.8%)。美国麻醉医师协会(ASA)评分、失血量、体能状态、腹膜癌指数(PCI)、大肠切除术、术后血清白蛋白水平和营养状况与术后感染性并发症的较高风险相关。

结论

接受细胞减灭术和腹腔内热灌注化疗的营养不良患者更容易发生术后感染性并发症,应考虑给予充分的围手术期营养支持,包括免疫增强营养。应连续监测常见感染部位,预防性抗真菌治疗念珠菌感染,并谨慎选择患者以降低并发症发生率。

相似文献

1
Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center.
Gastroenterol Res Pract. 2019 May 2;2019:2824073. doi: 10.1155/2019/2824073. eCollection 2019.
4
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
6
Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer.
World J Gastrointest Oncol. 2020 Aug 15;12(8):903-917. doi: 10.4251/wjgo.v12.i8.903.
10
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol. 2016 May;23(5):1609-17. doi: 10.1245/s10434-015-5012-3. Epub 2015 Dec 17.

引用本文的文献

1
Predicting Postoperative Infection After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Splenectomy.
Ann Surg Oncol. 2025 Apr;32(4):2903-2911. doi: 10.1245/s10434-024-16728-1. Epub 2025 Jan 22.
2
Novel technique and outcomes of umbilical reconstruction during cytoreductive surgery; a multi-centre study.
Tech Coloproctol. 2025 Jan 21;29(1):49. doi: 10.1007/s10151-024-03095-y.
7
High-protein home parenteral nutrition in malnourished oncology patients: a systematic literature review.
Support Care Cancer. 2023 Dec 22;32(1):52. doi: 10.1007/s00520-023-08218-z.
8
Etiological analysis of infection after CRS + HIPEC in patients with PMP.
BMC Cancer. 2023 Sep 26;23(1):903. doi: 10.1186/s12885-023-11404-1.

本文引用的文献

1
Obesity as a surgical risk factor.
Ann Gastroenterol Surg. 2017 Oct 28;2(1):13-21. doi: 10.1002/ags3.12049. eCollection 2018 Jan.
2
A positive association between nutritional risk and the incidence of surgical site infections: A hospital-based register study.
PLoS One. 2018 May 15;13(5):e0197344. doi: 10.1371/journal.pone.0197344. eCollection 2018.
4
Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.
Surg Infect (Larchmt). 2017 Feb/Mar;18(2):157-163. doi: 10.1089/sur.2016.102. Epub 2016 Dec 1.
5
Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.
Eur J Surg Oncol. 2017 Jun;43(6):1013-1027. doi: 10.1016/j.ejso.2016.09.008. Epub 2016 Sep 28.
7
Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis.
World J Surg Oncol. 2015 Oct 22;13:305. doi: 10.1186/s12957-015-0703-6.
9
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Oncotarget. 2015 May 30;6(15):13402-15. doi: 10.18632/oncotarget.2830.
10
Surgical infection and malnutrition.
Nutr Hosp. 2014 Sep 1;30(3):509-13. doi: 10.3305/nh.2014.30.3.7702.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验